July 28, 2026—Waters Corp. launched the Xevo TQ Absolute XR IVD mass spectrometer, expanding its MassTrak IVD system portfolio of LC-MS/MS systems. Developed for routine laboratory testing requiring in vitro diagnostic–compliant systems and built on the performance of the Xevo TQ Absolute IVD mass spectrometer, the Xevo TQ Absolute XR IVD system delivers trace-level analytical performance in complex biological matrices. With up to five times greater sensitivity than other instruments in its class, the system enables lower limits of detection and reliable quantification of challenging analytes from smaller sample volumes, according to a company news release.
“With the introduction of the Xevo TQ Absolute XR IVD system, Waters is delivering a new standard of sensitivity and robustness that can significantly reduce downtime and improve laboratory productivity,” Jianqing Bennett, senior vice president of Waters Advanced Diagnostics, said in the release. “Waters is uniquely positioned to help clinical laboratories develop reliable methods for complex analytes and expand their testing capabilities to meet growing demand across women’s health, cancer assessment, and toxicology applications.”
Featuring the new StepWave XR ion guide, the Xevo TQ Absolute XR IVD system delivers improved robustness, enabling ion ratio consistency for up to six times longer compared with the Xevo TQ Absolute IVD system. This aims to give laboratories greater confidence in consistent performance when analyzing complex clinical samples containing phospholipids, salts, and other matrix components. The new MassTrak LC-MS/MS IVD system includes the Acquity UPLC I-Class Plus system with the Xevo TQ Absolute XR IVD mass spectrometer.